PGP and Alzheimer disease: Polymorphisms to this transporter have been investigated as a possible link to P-gp dysfunction in AD [14], and the reduced abundance of the protein transporter is suggested to play a role in AD pathology itself [15], given P-gp is reported to clear the neurotoxin Aβ from the brain [16].